SCHEMBL8801437

SCHEMBL8801437

Cc1ccc(Cl)cc1-c1ccccc1C(=O)C(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 7/20 0.50
CES1 P23141 7/20 0.50
CHRM1 P11229 1/20 0.48
HTT P42858 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HSP90AA1 P07900 2/20 0.42
MITF O75030 1/20 0.42
ATM Q13315 1/20 0.42
TLR9 Q9NR96 1/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17454062 0.84 PTGER1 (0.55) CHRM1ALDH1A1HSP90AA1SMN1; SMN2KMT2A
SCHEMBL981886 0.82 CES2 (0.52) CES2CES1NPC1HPGDRAB9A
SCHEMBL24043882 0.82 CES2 (0.53) CES2CES1HTTNPSR1ALDH1A1
SCHEMBL29972427 0.79 CES2 (0.67) CES2CES1HTTALDH1A1LMNA
SCHEMBL7085442 0.77 SLC6A4 (0.39) CES2CES1MAPTSMN1; SMN2KMT2A
SCHEMBL28864516 0.76 CES2 (0.63) CES2CES1HSP90AA1SMN1; SMN2KMT2A
SCHEMBL8800748 0.76 CES2 (0.55) CES2CES1NPSR1ALDH1A1HSP90AA1
Ammonia Solution, Strong SCHEMBL27655386 0.76 CES2 (0.47) CES2CES1CHRM1ALDH1A1LMNA
SCHEMBL11082147 0.76 CYP2C8 (0.54) HTTNPSR1ALDH1A1HSP90AA1MITF
SCHEMBL11681422 0.74 HTT (0.55) HTTNPSR1ALDH1A1HSP90AA1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772601-A1 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed